| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3316647 | Pancreatology | 2016 | 11 Pages |
Abstract
The potential treatment with beta-blockers of patients with pancreatic cancer or other malignancies should be further evaluated as an adjuvant anti-neoplastic agent in clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Lars Ivo Partecke, Sven Speerforck, André Käding, Florian Seubert, Sandra Kühn, Eric Lorenz, Sebastian Schwandke, Matthias Sendler, Wolfram KeÃler, Dung Nguyen Trung, Stefan Oswald, Frank Ulrich Weiss, Julia Mayerle, Christin Henkel, Pia Menges,